Posted in | News | Imaging | Medical Optics

FUJIFILM Acquires Russian Distributor of its Medical and Imaging Products

FUJIFILM Corporation (President and CEO: Shigetaka Komori) has acquired, through its European local corporation, FUJIFILM Europe GmbH (President Shigehiro Nakajima), all shares in "FUJIFILM-RU" (herefater, Fujifilm Russia), a Russian independent distributor of its medical and imaging products, from Marubeni Corporation. Establishing a direct sale structure by turning an independent distributor into its own sbusidiary, Fujifilm will accelerate its business expansion in the Russian market where high economic growth is expected in the mid- to long-term.

Since its incoporation in 1993, Fujifilm Russia has established its customer base in Russia as a distributing company for imaging products such as photography related equipment and medical products. In particular, it has been creating new demand for digitalization in medical diagnostic imaging, such as expanding sales of the FCR*1 digital X-ray diagnostic imaging systems. In the future, under a direct sales structure, Fujifilm will strengthen its capabilities to provide total solutions including Fujifilm's global strategic product, the SYNAPSE*2 medical-use picture archiving and communication system. Furthermore, through marketing and sales activities, which respond immediately to market needs, it will push forward the expansion of its medical business in the healthcare market that is expected to grow rapidly.

In the imaging business, where digital camera is showing growth, Fujifilm will strengthen its organization by disseminating Fujifilm's digital printing solution to address diversifying user needs (a system that is able to provide easy and speedy ordering with various output methods) to capture the expanding value-added printing demand such as digital camera printing and Photobook, and expand business by increasing market share.

With the acquisition of Fujifilm Russia as a subsidiary, Fujifilm has established local corporations in all four BRICs countries and will strongly push forward with its growth strategy in the global market.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.